NUCERA SILVIA

Sindoni, M., Limido, F., Toso, A., Lucchini, G., Gaipa, G., Balduzzi, A., et al. (2025). aGvHDtrackR and cGvHDtrackR: shiny applications for graft versus host disease management and clinical data collection. BONE MARROW TRANSPLANTATION, 60(3), 389-392 [10.1038/s41409-025-02509-1]. Detail

Licari, E., Cricrì, G., Mauri, M., Raimondo, F., Dioni, L., Favero, C., et al. (2024). ActivinA modulates B-acute lymphoblastic leukaemia cell communication and survival by inducing extracellular vesicles production. SCIENTIFIC REPORTS, 14(1) [10.1038/s41598-024-66779-3]. Detail

Nucera, S., Sindoni, M., Bugarin, C., Villa, T., Biondi, A., Balduzzi, A., et al. (2024). A novel flow-cytometric based method to assess post-HSCT donor chimerism exploiting RNA hybridization. BONE MARROW TRANSPLANTATION, 59(2), 171-177 [10.1038/s41409-023-02143-9]. Detail

Nucera, S., Limido, F., Balduzzi, A. (2024). HSCT in the First CR and in the Subsequent CRs: Indications and Conditioning Regimens. In G. Escherich, V. Conter (a cura di), Acute Lymphoblastic Leukemia in Children and Adolescents (pp. 261-276). Springer Science and Business Media Deutschland GmbH [10.1007/978-3-031-71180-0_17]. Detail

Caserta, C., Nucera, S., Barcella, M., Fazio, G., Naldini, M., Pagani, R., et al. (2023). miR-126 identifies a quiescent and chemo-resistant human B-ALL cell subset that correlates with minimal residual disease. LEUKEMIA, 37(10), 1994-2005 [10.1038/s41375-023-02009-5]. Detail